BR9813296A - Molécula isolada de ácido nucleico, processo para identificar uma molécula de ácido nucleico codificando um polipeptìdeo de endoglucuronidase de mamìfero, vetor de expressão, peptìdeo de heparanase isolado, polipeptìdeo recombinante ou isolado, molécula de anticorpo, processo para identificar um modulador da atividade de heparanase, uso de um oligossacarìdeo sulfatado, um sulfonato ou hspg compreendendo os mesmos, processos para tratamento de uma condição fisiológica ou médica em um sujeito humano ou animal em que a atividade de heparanase no referido sujeito é elevada, para intensificar a cura de feridas em um sujeito humano ou animal e para diagnosticar uma condição fisiológica ou médica associada com a super-expressão de heparanase, e, célula - Google Patents
Molécula isolada de ácido nucleico, processo para identificar uma molécula de ácido nucleico codificando um polipeptìdeo de endoglucuronidase de mamìfero, vetor de expressão, peptìdeo de heparanase isolado, polipeptìdeo recombinante ou isolado, molécula de anticorpo, processo para identificar um modulador da atividade de heparanase, uso de um oligossacarìdeo sulfatado, um sulfonato ou hspg compreendendo os mesmos, processos para tratamento de uma condição fisiológica ou médica em um sujeito humano ou animal em que a atividade de heparanase no referido sujeito é elevada, para intensificar a cura de feridas em um sujeito humano ou animal e para diagnosticar uma condição fisiológica ou médica associada com a super-expressão de heparanase, e, célulaInfo
- Publication number
- BR9813296A BR9813296A BR9813296-2A BR9813296A BR9813296A BR 9813296 A BR9813296 A BR 9813296A BR 9813296 A BR9813296 A BR 9813296A BR 9813296 A BR9813296 A BR 9813296A
- Authority
- BR
- Brazil
- Prior art keywords
- heparanase
- subject
- human
- isolated
- physiological
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01166—Heparanase (3.2.1.166)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
"MOLéCULA ISOLADA DE áCIDO NUCLEICO, PROCESSO PARA IDENTIFICAR UMA MOLéCULA DE áCIDO NUCLEICO CODIFICANDO UM POLIPEPTìDEO DE ENDOGLUCURONIDASE DE MAMìFERO, VETOR DE EXPRESSãO, PEPTìDEO DE HEPARANASE ISOLADO, POLIPEPTìDEO RECOMBINANTE OU ISOLADO, MOLéCULA DE ANTICORPO, PROCESSO PARA IDENTIFICAR UM MODULADOR DA ATIVIDADE DE HEPARANASE, USO DE UM OLIGOSSACARìDEO SULFATADO, UM SULFONATO OU HSPG COMPREENDENDO OS MESMOS, PROCESSOS PARA TRATAMENTO DE UMA CONDIçãO FISIOLóGICA OU MéDICA EM UM SUJEITO HUMANO OU ANIMAL EM QUE A ATIVIDADE DE HEPARANASE NO REFERIDO SUJEITO é ELEVADA, PARA INTENSIFICAR A CURA DE FERIDAS EM UM SUJEITO HUMANO OU ANIMAL E PARA DIAGNOSTICAR UMA CONDIçãO FISIOLóGICA OU MéDICA ASSOCIADA COM A SUPER-EXPRESSãO DE HEPARANASE, E, CéLULA" A presente invenção refere-se a enzimas, polipeptídeos e peptídeos isolados ou recombinantes de endoglucuronidase de mamífero, em particular a heparanases humanas, murinos e de rato, a sequências genéticas codificando os mesmos, e a seus usos, por exemplo, na determinação e na caracterização de compostos químicos, proteínas, polipeptídeos, pequenas moléculas e macromoléculas capazes de inibir metástase, angiogênese, restenose induzida por angioplastia, ateroesclerose, inflamação, promover cura de feridas e, de outra forma, modular processos fisiológicos que envolvem a clivagem de heparanase do sulfato de heparano. A invenção também se refere a um processo para alterar, modificar ou, de outra forma, modular o nível de expressão da heparanase de mamífero em uma célula. Um outro aspecto da invenção refere-se a moléculas imunorreativas capazes de ligar-se a, e/ou inibir, a heparanase de mamífero. Em particular anticorpos monoclonais. Um outro aspecto adicional da invenção trata do uso de heparanase como um agente para promover os processos da cura de feridas.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP006297 AUPO006297A0 (en) | 1997-10-28 | 1997-10-28 | Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
AUPP0812A AUPP081297A0 (en) | 1997-12-09 | 1997-12-09 | Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therfor ii |
PCT/AU1998/000898 WO1999021975A1 (en) | 1997-10-28 | 1998-10-28 | Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9813296A true BR9813296A (pt) | 2000-08-22 |
Family
ID=25645639
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9813296-2A BR9813296A (pt) | 1997-10-28 | 1998-10-28 | Molécula isolada de ácido nucleico, processo para identificar uma molécula de ácido nucleico codificando um polipeptìdeo de endoglucuronidase de mamìfero, vetor de expressão, peptìdeo de heparanase isolado, polipeptìdeo recombinante ou isolado, molécula de anticorpo, processo para identificar um modulador da atividade de heparanase, uso de um oligossacarìdeo sulfatado, um sulfonato ou hspg compreendendo os mesmos, processos para tratamento de uma condição fisiológica ou médica em um sujeito humano ou animal em que a atividade de heparanase no referido sujeito é elevada, para intensificar a cura de feridas em um sujeito humano ou animal e para diagnosticar uma condição fisiológica ou médica associada com a super-expressão de heparanase, e, célula |
Country Status (9)
Country | Link |
---|---|
US (1) | US6242238B1 (pt) |
EP (1) | EP1032656A4 (pt) |
JP (1) | JP2002510462A (pt) |
CN (1) | CN1280613A (pt) |
AU (1) | AU744655B2 (pt) |
BR (1) | BR9813296A (pt) |
CA (1) | CA2307830A1 (pt) |
IL (1) | IL135823A0 (pt) |
WO (1) | WO1999021975A1 (pt) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6562950B2 (en) * | 1997-09-02 | 2003-05-13 | Insight Strategy & Marketing Ltd. | Heparanase activity neutralizing anti-heparanase monoclonal antibody |
US6699672B1 (en) | 1997-09-02 | 2004-03-02 | Insight Biopharmaceuticals Ltd. | Heparanase specific molecular probes and their use research and medical applications |
US20030161823A1 (en) * | 1998-08-31 | 2003-08-28 | Neta Ilan | Therapeutic and cosmetic uses of heparanases |
US20010006630A1 (en) * | 1997-09-02 | 2001-07-05 | Oron Yacoby-Zeevi | Introducing a biological material into a patient |
US6348344B1 (en) * | 1997-09-02 | 2002-02-19 | Insight Strategy & Marketing Ltd. | Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
US20020088019A1 (en) * | 1997-09-02 | 2002-07-04 | Oron Yacoby-Zeevi | Methods of and pharmaceutical compositions for improving implantation of embryos |
US5968822A (en) * | 1997-09-02 | 1999-10-19 | Pecker; Iris | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
US6177545B1 (en) | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
US20040213789A1 (en) * | 1997-09-02 | 2004-10-28 | Oron Yacoby-Zeevi | Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies |
GB9802725D0 (en) | 1998-02-09 | 1998-04-08 | Ciba Geigy Ag | Organic compounds |
US20020068054A1 (en) * | 2000-09-11 | 2002-06-06 | Insight Strategy & Marketing Ltd. And Hadasit Medical Research Services And Development Ltd. | Therapeutic and cosmetic uses of heparanases |
WO2000052178A1 (en) * | 1999-03-01 | 2000-09-08 | Insight Strategy & Marketing Ltd. | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells |
CN1370178A (zh) * | 1999-06-25 | 2002-09-18 | 洞察战略及销售有限公司 | 多核苷酸及其编码的与乙酰肝素酶同源较远的多肽 |
EP1214423A1 (en) * | 1999-09-23 | 2002-06-19 | MERCK PATENT GmbH | Heparanase-2, a member of the heparanase protein family |
WO2001046392A2 (en) * | 1999-12-22 | 2001-06-28 | Oxford Glycosciences (Uk) Ltd. | Homologues of human heparanase and splice variants thereof |
JP2003518381A (ja) * | 1999-12-23 | 2003-06-10 | シエーリング アクチエンゲゼルシャフト | ヒトヘパラナーゼ関連ポリペプチド及び核酸 |
GB0008912D0 (en) * | 2000-04-11 | 2000-05-31 | Janssen Pharmaceutica Nv | Mammalian heparanase |
PL366012A1 (en) | 2000-09-15 | 2005-01-24 | Reddy Us Therapeutics, Inc. | Methods and compositions for glycosidase assays |
US6677137B2 (en) * | 2000-09-20 | 2004-01-13 | Insight Strategy & Marketing Ltd. | Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activity |
EP1333862A4 (en) * | 2000-10-17 | 2004-08-18 | Insight Strategy & Marketing | PHARMACEUTICAL METHODS AND COMPOSITIONS FOR IMPROVING THE ESTABLISHMENT OF EMBRYOS |
EP1379139A4 (en) * | 2000-12-19 | 2004-12-01 | Insight Strategy & Marketing | USE OF ECM DEGRADING ENZYME TO IMPROVE CELL TRANSPLANTATION |
US6630295B2 (en) * | 2001-01-04 | 2003-10-07 | Insight Strategy & Marketing Ltd. | High throughput assay for monitoring polycation or polyanion molecular weight, degradation or synthesis |
US20040247577A1 (en) * | 2001-07-13 | 2004-12-09 | Peter Bohlen | Method and composition for inhibiting heparanase activity |
JP2005521379A (ja) * | 2001-07-13 | 2005-07-21 | イムクローン システムズ インコーポレイティド | ヘパラナーゼ活性を阻害するための方法及び組成物 |
WO2003042366A2 (en) * | 2001-11-13 | 2003-05-22 | Albert Einstein College Of Medicine Of Yeshiva University | A novel saitohin gene and uses of same |
US20030234212A1 (en) * | 2002-06-21 | 2003-12-25 | Sanden Corporation | Mineral water making apparatus |
WO2004043989A2 (en) * | 2002-11-07 | 2004-05-27 | Medarex, Inc. | Human monoclonal antibodies to heparanase |
EP1479764A1 (en) | 2003-05-19 | 2004-11-24 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Heparanase-derived peptides for vaccination of tumor patients |
IL162276A0 (en) * | 2004-06-01 | 2005-11-20 | Hadasit Med Res Service | Nucleic acid molecules as heparanase potent inhibitors, compositions and methods of use thereof |
CN100462432C (zh) * | 2006-03-15 | 2009-02-18 | 中国人民解放军军事医学科学院野战输血研究所 | 杂交瘤细胞株及其产生的抗人肝素酶单克隆抗体 |
CN114793437A (zh) * | 2019-04-30 | 2022-07-26 | Encodia 公司 | 用于从多肽上切割n端氨基酸的方法和试剂 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0532695A1 (en) | 1990-05-31 | 1993-03-24 | Board Of Regents, The University Of Texas System | Immunochemical localization of heparanase in mouse and human melanomas |
AU7368994A (en) * | 1993-07-29 | 1995-02-28 | Upjohn Company, The | Use of heparanase to identify and isolate anti-heparanase compound |
TW565614B (en) | 1996-07-18 | 2003-12-11 | Univ Australian | Detection of mammalian heparanase activity and purification of mammalian heparanase |
US5968822A (en) | 1997-09-02 | 1999-10-19 | Pecker; Iris | Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells |
-
1998
- 1998-10-28 IL IL13582398A patent/IL135823A0/xx unknown
- 1998-10-28 BR BR9813296-2A patent/BR9813296A/pt not_active IP Right Cessation
- 1998-10-28 CA CA002307830A patent/CA2307830A1/en not_active Abandoned
- 1998-10-28 JP JP2000518067A patent/JP2002510462A/ja not_active Withdrawn
- 1998-10-28 WO PCT/AU1998/000898 patent/WO1999021975A1/en not_active Application Discontinuation
- 1998-10-28 AU AU10109/99A patent/AU744655B2/en not_active Ceased
- 1998-10-28 CN CN98811662A patent/CN1280613A/zh active Pending
- 1998-10-28 US US09/181,336 patent/US6242238B1/en not_active Expired - Fee Related
- 1998-10-28 EP EP19980952409 patent/EP1032656A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US6242238B1 (en) | 2001-06-05 |
AU744655B2 (en) | 2002-02-28 |
EP1032656A1 (en) | 2000-09-06 |
CA2307830A1 (en) | 1999-05-06 |
WO1999021975A1 (en) | 1999-05-06 |
AU1010999A (en) | 1999-05-17 |
CN1280613A (zh) | 2001-01-17 |
EP1032656A4 (en) | 2002-10-29 |
IL135823A0 (en) | 2001-05-20 |
JP2002510462A (ja) | 2002-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9813296A (pt) | Molécula isolada de ácido nucleico, processo para identificar uma molécula de ácido nucleico codificando um polipeptìdeo de endoglucuronidase de mamìfero, vetor de expressão, peptìdeo de heparanase isolado, polipeptìdeo recombinante ou isolado, molécula de anticorpo, processo para identificar um modulador da atividade de heparanase, uso de um oligossacarìdeo sulfatado, um sulfonato ou hspg compreendendo os mesmos, processos para tratamento de uma condição fisiológica ou médica em um sujeito humano ou animal em que a atividade de heparanase no referido sujeito é elevada, para intensificar a cura de feridas em um sujeito humano ou animal e para diagnosticar uma condição fisiológica ou médica associada com a super-expressão de heparanase, e, célula | |
Godwin et al. | The role of fibrillin and microfibril binding proteins in elastin and elastic fibre assembly | |
Miura et al. | Decorin binds myostatin and modulates its activity to muscle cells | |
Gallagher | The extended family of proteoglycans: social residents of the pericellular zone | |
Stanton et al. | Proteoglycan degradation by the ADAMTS family of proteinases | |
Midwood et al. | Coregulation of fibronectin signaling and matrix contraction by tenascin-C and syndecan-4 | |
Enghild et al. | Chondroitin 4-sulfate covalently cross-links the chains of the human blood protein pre-alpha-inhibitor. | |
Elefteriou et al. | Binding of tenascin-X to decorin | |
Buono et al. | Sulfatase activities towards the regulation of cell metabolism and signaling in mammals | |
Chamley et al. | Distinction between smooth muscle, fibroblasts and endothelial cells in culture by the use of fluoresceinated antibodies against smooth muscle actin | |
JP2011120595A (ja) | 成長因子複合体ならびに細胞の移動および増殖の調節 | |
Nagaoka et al. | Effects of cofilin on actin filamentous structures in cultured muscle cells: intracellular regulation of cofilin action | |
Knaust et al. | Residues critical for formylglycine formation and/or catalytic activity of arylsulfatase A | |
Ciglic et al. | Origin of dimeric structure in the ribonuclease superfamily | |
Muthusamy et al. | Soluble perlecan domain I enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells | |
Ramshaw et al. | Recent progress with recombinant collagens produced in Escherichia coli | |
Butterfield et al. | Identification and sequence composition characterization of chondroitin sulfate-binding peptides through peptide array screening | |
Anderegg et al. | Collagen/glycosaminoglycan-based matrices for controlling skin cell responses | |
Kuo et al. | The Macromolecular Structure of Type‐VI Collagen: Formation and Stability of Filaments | |
Harris et al. | GnRH increases glucose transporter-1 expression and stimulates glucose uptake in the gonadotroph | |
ATE348171T1 (de) | Proteine mit lecithin-cholesterin acetyltransferase-ähnlicher aktivität, deren herstellung und verwendung | |
Erickson et al. | Basement membrane and interstitial proteoglycans produced by MDCK cells correspond to those expressed in the kidney cortex | |
Klatt et al. | The matrilin-3 VWA1 domain modulates interleukin-6 release from primary human chondrocytes | |
Erlich et al. | Major glycosaminoglycan species in the developing retina: synthesis, tissue distribution and effects upon cell death | |
Sandy | Proteoglycan core proteins and catabolic fragments present in tissues and fluids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A,8A E 9A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007. |